PITTSBURGH, Jan. 21 /PRNewswire/ -- Precision Therapeutics, Inc. today announced that CEO Sean McDonald provided a company presentation at the J.P. Morgan 28th Annual Healthcare Conference, held at the Westin St. Francis Hotel in San Francisco, California, on Thursday, January 14, 2010. The presentation included a discussion of the company's marketed products, its strategy for growth, and other matters relating to its business.
Precision's ChemoFx(R), a proprietary drug response marker, measures an individual patient's tumor response to various chemotherapeutic and biological agents prior to treating the patient. ChemoFx(R) can complement the physician's experience and provide valuable patient-specific information, as there is typically not a uniform response to standard cancer treatment or no clear choice for the next regimen.
Precision Therapeutics, Inc.
